Skip to Content


In the US, Deferoxamine (deferoxamine systemic) is a member of the following drug classes: antidotes, chelating agents and is used to treat Iron Poisoning - Acute and Iron Poisoning - Chronic.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Iron chelator

Chemical Name

Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-

Foreign Names

  • Deferoxaminum (Latin)
  • Deferoxamin (German)
  • Déferoxamine (French)
  • Deferoxamina (Spanish)

Generic Names

Brand Names

  • Deferoxamine Noridem
    Noridem, Cyprus
  • Desferal
    2care4, Norway; Novartis, Egypt; Novartis, Turkey; Novartis, Vietnam; Novartis Pharmaceuticals, Cyprus
  • Desféral
    Novartis, Tunisia
  • Desferrioxamine Mesilate
    Hospira, Cyprus
  • Desferrioxamine Mesilate Hospira (Deferoxamine and Deferoxamine)
    Hospira UK, United Kingdom
  • Desferal
    Euro Registratie, Netherlands; Fisher Farma, Netherlands; Novartis, Argentina; Novartis, Belgium; Novartis, Bulgaria; Novartis, Brazil; Novartis, Chile; Novartis, Czech Republic; Novartis, Denmark; Novartis, Finland; Novartis, Greece; Novartis, Hong Kong; Novartis, Hungary; Novartis, Indonesia; Novartis, Ireland; Novartis, Israel; Novartis, Iceland; Novartis, Japan; Novartis, Malta; Novartis, Netherlands; Novartis, Norway; Novartis, Oman; Novartis, Poland; Novartis, Portugal; Novartis, Romania; Novartis, Sweden; Novartis, Thailand; Novartis, Taiwan; Novartis, United States; Novartis, Venezuela; Novartis AH, South Africa; Novartis Farma, Italy; Novartis Healthcare, Philippines; Novartis Pharma, Austria; Novartis Pharma, Switzerland; Novartis Pharma, Germany; Novartis Pharmaceuticals, Australia; Novartis Pharmaceuticals, Canada; Novartis Pharmaceuticals UK, United Kingdom
  • Desféral
    Novartis, France
  • Desferin
    Grupo Novartis, Spain
  • Desferrioxamine Mesilate Hospira
    Hospira, Malta; Hospira, Taiwan
  • Desferrioxamine Mesilate Hospira (Deferoxamine and Deferoxamine)
    Hospira UK, United Kingdom
  • Desferrioxamine Mesylate DBL
    Hospira, New Zealand
  • PMS-Deferoxamine
    Pharmascience, Canada


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Prop.INNProposed International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.